Perspectives of adolescents and young adults with advanced cancer on complete genomic analysis in standard oncology care
AYAs with advanced cancer generally value WGS, even when results have no immediate clinical consequences. They describe benefits such as hope, reassurance and the opportunity to help future patients. However, misunderstandings about its purpose, difficulties in interpreting genomic findings and limited awareness of potential hereditary implications may limit its optimal use. Strengthening communication with age-appropriate, accessible explanatory materials will be essential to ensure AYAs understand the purpose and potential outcomes of WGS and can fully benefit from its implementation.
Authors
- Winette T. A van der Graaf
- Mathijs P. Hendriks (ORCID: https://orcid.org/0000-0001-6687-5393)
- Milou J. P. Reuvers
- Lina H. Lankhorst (ORCID: https://orcid.org/0000-0003-2147-0469)
- Noor A. A. Giesbertz (ORCID: https://orcid.org/0000-0001-5664-8883)
- Olga Husson (ORCID: https://orcid.org/0000-0002-1387-8686)
- Baukje Flameling
- Helle-Brit Fiebrich-Westra
- Madelief van de Ree
- Jelmer Gietema
- Lenneke Stabel
- Lizet E van der Kolk
Institutions
- Erasmus MC (NL)
- The Netherlands Cancer Institute (NL)
- Partners In Care (US)
- Northwest Hospital (US)
- OLVG (NL)
- Isala (NL)
- Erasmus MC Cancer Institute (NL)
Publication Details
- Journal
- Journal of Medical Genetics
- Published
- 2026-03-27
- DOI
- https://doi.org/10.1136/jmg-2025-111368
- Primary Topic
- Childhood Cancer Survivors' Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00